Pharmacological enhancement of exposure-based treatment in PTSD: a qualitative review (Q22305514)

7 February 2023

2

Barbara O

Rothbaum

Barbara O Rothbaum

1 reference

7 February 2023

Agnes van Minnen

3

Agnes

van Minnen

1 reference

24147208

European journal of psychotraumatology

7 February 2023

language of work or name

English

0 references

publication date

2013

0 references

published in

1 reference

Creative Commons Attribution-NonCommercial 3.0 Unported

volume

4

0 references

issue

0

0 references

copyright license

start time

17 October 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800126

Combined Prolonged Exposure Therapy and Paroxetine for PTSD Related to the World Trade Center Attack: A Randomized Controlled Trial

19 March 2017

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800126

The safety and efficacy of { /-}3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study

19 March 2017

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800126

A randomized clinical trial to dismantle components of cognitive processing therapy for posttraumatic stress disorder in female victims of interpersonal violence

19 March 2017

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800126

Psychological treatment of post-traumatic stress disorder (PTSD)

19 March 2017

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800126

Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey Replication

19 March 2017

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800126

Pharmacological treatment of anxiety disorders: current treatments and future directions

19 March 2017

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800126

Examining potential contraindications for prolonged exposure therapy for PTSD

19 March 2017

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800126

Emotion: clues from the brain

19 March 2017

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800126

Duloxetine inhibits effects of MDMA ("ecstasy") in vitro and in humans in a randomized placebo-controlled laboratory study

19 March 2017

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800126

A role for oxytocin and 5-HT(1A) receptors in the prosocial effects of 3,4 methylenedioxymethamphetamine ("ecstasy")

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800126

Extinction learning in humans: role of the amygdala and vmPFC

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800126

Implications of memory modulation for post-traumatic stress and fear disorders

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800126

D-cycloserine enhancement of fear extinction is specific to successful exposure sessions: evidence from the treatment of height phobia.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800126

Propranolol's effects on the consolidation and reconsolidation of long-term emotional memory in healthy participants: a meta-analysis

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800126

A randomized, controlled pilot study of MDMA (± 3,4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic Post-Traumatic Stress Disorder (PTSD).

27 September 2017

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800126

27 September 2017

https://api.crossref.org/works/10.3402/EJPT.V4I0.21626

Augmentation of exposure therapy with post-session administration of D-cycloserine

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800126

Glucocorticoid augmentation of prolonged exposure therapy: rationale and case report

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800126

Integrated exposure-based therapy for co-occurring posttraumatic stress disorder and substance dependence: a randomized controlled trial

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800126

Pharmacological innovations for posttraumatic stress disorder and medication- enhanced psychotherapy

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800126

D-cycloserine augmentation of behavioral therapy for the treatment of anxiety disorders: a meta-analysis.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800126

Glucocorticoids enhance extinction-based psychotherapy.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800126

A review of safety, side-effects and subjective reactions to intranasal oxytocin in human research.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800126

Pharmacological enhancement of behavioral therapy: focus on posttraumatic stress disorder

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800126

Effects of exogenous glucocorticoid on combat-related PTSD symptoms

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800126

A meta-analytic review of prolonged exposure for posttraumatic stress disorder

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800126

Increased oxytocin concentrations and prosocial feelings in humans after ecstasy (3,4-methylenedioxymethamphetamine) administration.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800126

Glucocorticoids and the regulation of memory in health and disease

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800126

Beyond extinction: erasing human fear responses and preventing the return of fear

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800126

MDMA-assisted psychotherapy using low doses in a small sample of women with chronic posttraumatic stress disorder.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800126

Physiological and subjective responses to controlled oral 3,4-methylenedioxymethamphetamine administration

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800126

Paroxetine CR augmentation for posttraumatic stress disorder refractory to prolonged exposure therapy

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800126

A meta-analysis of D-cycloserine and the facilitation of fear extinction and exposure therapy

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800126

Optimizing inhibitory learning during exposure therapy

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800126

Effect of post-retrieval propranolol on psychophysiologic responding during subsequent script-driven traumatic imagery in post-traumatic stress disorder

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800126

D-cycloserine augmented exposure therapy for obsessive-compulsive disorder

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800126

Cognitive behavioral therapy for posttraumatic stress disorder in women: a randomized controlled trial

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800126

A randomized controlled trial of the effect of D-cycloserine on exposure therapy for spider fear

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800126

Glucocorticoids reduce phobic fear in humans

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800126

Augmentation of exposure therapy with D-cycloserine for social anxiety disorder.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800126

A review of acute effects of 3,4-methylenedioxymethamphetamine in healthy volunteers

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800126

A multidimensional meta-analysis of psychotherapy for PTSD.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800126

Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800126

Disruption of reconsolidation but not consolidation of auditory fear conditioning by noradrenergic blockade in the amygdala

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800126

Facilitation of fear extinction by D-cycloserine: theoretical and clinical implications.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800126

Low-dose cortisol for symptoms of posttraumatic stress disorder

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800126

Memory reconsolidation and extinction have distinct temporal and biochemical signatures.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800126

The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800126

Fear activation and habituation patterns as early process predictors of response to prolonged exposure treatment in PTSD.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800126

Efficacy of sertraline in preventing relapse of posttraumatic stress disorder: results of a 28-week double-blind, placebo-controlled study

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800126

Human pharmacology of 3,4-methylenedioxymethamphetamine ("ecstasy"): psychomotor performance and subjective effects

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800126

Context, time, and memory retrieval in the interference paradigms of Pavlovian learning

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800126

Protein synthesis and memory: a review

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800126

27 September 2017

2 references

https://api.crossref.org/works/10.3402/EJPT.V4I0.21626

21 January 2018

https://api.crossref.org/works/10.3402/EJPT.V4I0.21626

7 January 2021

inferred from DOI database lookup

Treatment of PTSD: a comparison of imaginal exposure with and without imagery rescripting

1 reference

https://api.crossref.org/works/10.3402/EJPT.V4I0.21626

Randomized trial of prolonged exposure for posttraumatic stress disorder with and without cognitive restructuring: outcome at academic and community clinics

21 January 2018

1 reference

https://api.crossref.org/works/10.3402/EJPT.V4I0.21626

MDMA as a clinical tool: a note of caution. A response to Sessa and Nutt.

21 January 2018

1 reference

https://api.crossref.org/works/10.3402/EJPT.V4I0.21626

MDMA enhances "mind reading" of positive emotions and impairs "mind reading" of negative emotions

21 January 2018

1 reference

https://api.crossref.org/works/10.3402/EJPT.V4I0.21626

How could MDMA (ecstasy) help anxiety disorders? A neurobiological rationale

21 January 2018

1 reference

https://api.crossref.org/works/10.3402/EJPT.V4I0.21626

Reconsolidation in a human fear conditioning study: a test of extinction as updating mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.3402/EJPT.V4I0.21626

Effects of D-cycloserine on extinction of conditioned freezing

21 January 2018

1 reference

https://api.crossref.org/works/10.3402/EJPT.V4I0.21626

Acute psychological effects of 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") are attenuated by the serotonin uptake inhibitor citalopram

21 January 2018

1 reference

https://api.crossref.org/works/10.3402/EJPT.V4I0.21626

Temporally graded requirement for protein synthesis following memory reactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.3402/EJPT.V4I0.21626

Trauma, PTSD, and substance use disorders: findings from the Australian National Survey of Mental Health and Well-Being.

21 January 2018

1 reference

https://api.crossref.org/works/10.3402/EJPT.V4I0.21626

Efficacy of d-cycloserine for enhancing response to cognitive-behavior therapy for panic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3402/EJPT.V4I0.21626

d-Cycloserine does not improve but might slightly speed up the outcome of in-vivo exposure therapy in patients with severe agoraphobia and panic disorder in a randomized double blind clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3402/EJPT.V4I0.21626

D-cycloserine does not enhance exposure-response prevention therapy in obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3402/EJPT.V4I0.21626

A randomized placebo-controlled trial of D-cycloserine and exposure therapy for posttraumatic stress disorder

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800126

A psychobiological rationale for oxytocin in the treatment of posttraumatic stress disorder

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800126

Is there a case for MDMA-assisted psychotherapy in the UK?

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800126

Facilitation of conditioned fear extinction by systemic administration or intra-amygdala infusions of D-cycloserine as assessed with fear-potentiated startle in rats.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800126

Trauma Reactivation Under the Influence of Propranolol Decreases Posttraumatic Stress Symptoms and Disorder

29 November 2018

1 reference

12 December 2020

A randomized placebo-controlled trial of D-cycloserine to enhance exposure therapy for posttraumatic stress disorder

1 reference

12 December 2020

Effects of D-cycloserine on extinction: consequences of prior exposure to imipramine

1 reference

12 December 2020

Augmentation of sertraline with prolonged exposure in the treatment of posttraumatic stress disorder

1 reference

12 December 2020

A systematic review of the efficacy of adding nonexposure components to exposure therapy for posttraumatic stress disorder

1 reference

https://api.crossref.org/works/10.3402/EJPT.V4I0.21626

7 January 2021

inferred from DOI database lookup

Trauma, PTSD, and Substance Use Disorders: Findings From the Australian National Survey of Mental Health and Well-Being

1 reference

https://api.crossref.org/works/10.3402/EJPT.V4I0.21626

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.3402/EJPT.V4I0.21626

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

4182572

OpenCitations bibliographic resource ID

4182572

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

4182572

PMC publication ID

3800126

0 references